Ciprofloxacin and rifampin have opposite effects on levothyroxine absorption. 2013

Alyse S Goldberg, and Rommel G Tirona, and Linda J Asher, and Richard B Kim, and Stan H M Van Uum
1 Division of Endocrinology and Metabolism, Department of Medicine, Schulich School of Medicine and Dentistry, Western University , London, Canada .

BACKGROUND Levothyroxine (L-T4) absorption varies between individuals, and can be affected by various concomitantly administered drugs. Case reports have indicated an association between cotreatment with ciprofloxacin or rifampin and hypothyroidism in patients on a stable L-T4 dose. METHODS The effects of two antibiotics on T4 absorption were prospectively assessed in a double-blind, randomized, crossover fashion. Eight healthy volunteers received 1000 μg L-T4 combined with placebo, ciprofloxacin 750 mg, or rifampin 600 mg as single doses. We measured total plasma thyroxine (T4) concentrations over a 6-hour period after dosing using liquid chromatography-tandem mass spectrometry. For each study arm, areas under the T4 plasma concentration-time curve (T4 AUCs) were compared. RESULTS Coadministration of ciprofloxacin significantly decreased the T4 AUC by 39% (p = 0.035), while, surprisingly, rifampin significantly increased T4 AUC by 25% (p = 0.003). CONCLUSIONS Intestinal absorption of L-T4 is differentially affected by acute coadministration of ciprofloxacin or rifampin. Mechanistic studies focused on intestinal and possibly hepatic thyroid hormone transporters are required to explain the observed drug interactions with L-T4.

UI MeSH Term Description Entries
D007037 Hypothyroidism A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction. Central Hypothyroidism,Primary Hypothyroidism,Secondary Hypothyroidism,TSH Deficiency,Thyroid-Stimulating Hormone Deficiency,Central Hypothyroidisms,Deficiency, TSH,Deficiency, Thyroid-Stimulating Hormone,Hormone Deficiency, Thyroid-Stimulating,Hypothyroidism, Central,Hypothyroidism, Primary,Hypothyroidism, Secondary,Hypothyroidisms,Primary Hypothyroidisms,Secondary Hypothyroidisms,TSH Deficiencies,Thyroid Stimulating Hormone Deficiency,Thyroid-Stimulating Hormone Deficiencies
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Alyse S Goldberg, and Rommel G Tirona, and Linda J Asher, and Richard B Kim, and Stan H M Van Uum
May 1999, Southern medical journal,
Alyse S Goldberg, and Rommel G Tirona, and Linda J Asher, and Richard B Kim, and Stan H M Van Uum
August 1998, Thyroid : official journal of the American Thyroid Association,
Alyse S Goldberg, and Rommel G Tirona, and Linda J Asher, and Richard B Kim, and Stan H M Van Uum
September 2005, British journal of clinical pharmacology,
Alyse S Goldberg, and Rommel G Tirona, and Linda J Asher, and Richard B Kim, and Stan H M Van Uum
January 1999, The Annals of pharmacotherapy,
Alyse S Goldberg, and Rommel G Tirona, and Linda J Asher, and Richard B Kim, and Stan H M Van Uum
March 2012, Molecular pharmacology,
Alyse S Goldberg, and Rommel G Tirona, and Linda J Asher, and Richard B Kim, and Stan H M Van Uum
April 2003, Neuroendocrinology,
Alyse S Goldberg, and Rommel G Tirona, and Linda J Asher, and Richard B Kim, and Stan H M Van Uum
April 2011, The Journal of biological chemistry,
Alyse S Goldberg, and Rommel G Tirona, and Linda J Asher, and Richard B Kim, and Stan H M Van Uum
January 2017, PloS one,
Alyse S Goldberg, and Rommel G Tirona, and Linda J Asher, and Richard B Kim, and Stan H M Van Uum
January 1983, Drug-nutrient interactions,
Alyse S Goldberg, and Rommel G Tirona, and Linda J Asher, and Richard B Kim, and Stan H M Van Uum
October 2012, The Journal of physiology,
Copied contents to your clipboard!